Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combinatorial CRISPR screen identifies fitness effects of gene paralogues
Nicola Thompson, Marco Ranzani, Louise van der Weyden, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 101

Showing 1-25 of 101 citing articles:

CRISPR in cancer biology and therapy
Alyna Katti, Bianca J. Diaz, Christina M. Caragine, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 5, pp. 259-279
Open Access | Times Cited: 299
Retention of duplicated genes in evolution
Elena Kuzmin, John S. Taylor, Charles Boone
Trends in Genetics (2021) Vol. 38, Iss. 1, pp. 59-72
Open Access | Times Cited: 151
Revolutionizing DNA repair research and cancer therapy with CRISPR–Cas screens
Samah W. Awwad, Almudena Serrano-Benítez, John C. Thomas, et al.
Nature Reviews Molecular Cell Biology (2023) Vol. 24, Iss. 7, pp. 477-494
Closed Access | Times Cited: 51
A comprehensive clinically informed map of dependencies in cancer cells and framework for target prioritization
Clare Pacini, Emma L. Duncan, Emanuel Gonçalves, et al.
Cancer Cell (2024) Vol. 42, Iss. 2, pp. 301-316.e9
Open Access | Times Cited: 34
Efficient gene knockout and genetic interaction screening using the in4mer CRISPR/Cas12a multiplex knockout platform
Nazanin Esmaeili Anvar, Chenchu Lin, Xingdi Ma, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 22
The genetic interaction map of the human solute carrier superfamily
Gernot Wolf, Philipp Leippe, Svenja Onstein, et al.
Molecular Systems Biology (2025)
Open Access | Times Cited: 4
Solute carriers: The gatekeepers of metabolism
Artem Khan, Yuyang Liu, Mark Gad, et al.
Cell (2025) Vol. 188, Iss. 4, pp. 869-884
Closed Access | Times Cited: 2
Discovery of synthetic lethal and tumor suppressor paralog pairs in the human genome
Phoebe C. R. Parrish, James D. Thomas, Austin M. Gabel, et al.
Cell Reports (2021) Vol. 36, Iss. 9, pp. 109597-109597
Open Access | Times Cited: 83
Comprehensive prediction of robust synthetic lethality between paralog pairs in cancer cell lines
Barbara De Kegel, Niall Quinn, Nicola Thompson, et al.
Cell Systems (2021) Vol. 12, Iss. 12, pp. 1144-1159.e6
Open Access | Times Cited: 57
Interrogation of cancer gene dependencies reveals paralog interactions of autosome and sex chromosome-encoded genes
Anna Köferle, Andreas Schlattl, Alexandra Hörmann, et al.
Cell Reports (2022) Vol. 39, Iss. 2, pp. 110636-110636
Open Access | Times Cited: 39
Targeting synthetic lethal paralogs in cancer
Colm J. Ryan, Ishan Mehta, Narod Kebabci, et al.
Trends in cancer (2023) Vol. 9, Iss. 5, pp. 397-409
Open Access | Times Cited: 39
CROPseq-multi: a versatile solution for multiplexed perturbation and decoding in pooled CRISPR screens
Russell T. Walton, Yue Qin, Paul C. Blainey
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 9
Unveiling prognostic value of JAK/STAT signaling pathway related genes in colorectal cancer: a study of Mendelian randomization analysis
Nan Zhang, Wenli Yue, Bo Jiao, et al.
Infectious Agents and Cancer (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Control of ciliary transcriptional programs during spermatogenesis by antagonistic transcription factors
Weihua Wang, Junqiao Xing, Xiqi Zhang, et al.
eLife (2025) Vol. 13
Open Access | Times Cited: 1
High throughput CRISPR approaches: New solutions for challenging problems
Gargi Bindal, Chitra Seetharam Misra, Mandeep Singh, et al.
TrAC Trends in Analytical Chemistry (2025), pp. 118245-118245
Closed Access | Times Cited: 1
Targeting key proteins involved in transcriptional regulation for cancer therapy: Current strategies and future prospective
Haixiang Pei, Weikai Guo, Yangrui Peng, et al.
Medicinal Research Reviews (2022) Vol. 42, Iss. 4, pp. 1607-1660
Closed Access | Times Cited: 31
The RNA helicase DDX39A binds a conserved structure in chikungunya virus RNA to control infection
Iulia Tapescu, Frances Taschuk, Swechha M. Pokharel, et al.
Molecular Cell (2023) Vol. 83, Iss. 22, pp. 4174-4189.e7
Open Access | Times Cited: 19
The present and future of the Cancer Dependency Map
Rand Arafeh, Tsukasa Shibue, Joshua M. Dempster, et al.
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 8
Comparative optimization of combinatorial CRISPR screens
Ruitong Li, Olaf Klingbeil, Davide Monducci, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 28
Genome-wide CRISPR screens using isogenic cells reveal vulnerabilities conferred by loss of tumor suppressors
Xu Feng, Mengfan Tang, Merve Dede, et al.
Science Advances (2022) Vol. 8, Iss. 19
Open Access | Times Cited: 28
E3 ubiquitin ligase ASB8 promotes selinexor-induced proteasomal degradation of XPO1
Bert Kwanten, Tine Deconick, Christopher J. Walker, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114305-114305
Open Access | Times Cited: 16
Applications of CRISPR-Cas9 for advancing precision medicine in oncology: from target discovery to disease modeling
Mirunalini Ravichandran, Danilo Maddalo
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 16
MARK2/MARK3 Kinases Are Catalytic Codependencies of YAP/TAZ in Human Cancer
Olaf Klingbeil, Damianos Skopelitis, Claudia Tonelli, et al.
Cancer Discovery (2024) Vol. 14, Iss. 12, pp. 2471-2488
Open Access | Times Cited: 5
Benchmarking machine learning methods for synthetic lethality prediction in cancer
Yimiao Feng, Yahui Long, He Wang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Synthetic lethal strategies for the development of cancer therapeutics
Natalie Ngoi, David Gallo, C. Sevillano, et al.
Nature Reviews Clinical Oncology (2024)
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top